Evidence map›Paper›PMID 37611220›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.

Madison Kilbride, Brian L Egleston, Wendy K Chung, Olufunmilayo Olopade, Kara N Maxwell, Payal Shah, Jane E Churpek, Linda Fleisher, Mary Beth Terry, Dominique Fetzer and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 6 institutions in 1 country.

Madison KilbrideDepartment of Philosophy, University of Utah, Salt Lake City, UT.ORCID 0000-0002-8923-9944
Brian L EglestonFox Chase Cancer Center, Temple University, Philadelphia, PA.ORCID 0000-0002-1633-799X
Wendy K ChungDepartment of Pediatrics and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York City, NY.ORCID 0000-0003-3438-5685
Olufunmilayo OlopadeThe University of Chicago, Chicago, IL.ORCID 0000-0002-9936-1599
Kara N MaxwellDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-8192-4202
Payal ShahDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-5874-3390
Jane E ChurpekThe University of Chicago, Chicago, IL.
Linda FleisherFox Chase Cancer Center, Temple University, Philadelphia, PA.ORCID 0000-0002-6911-0756
Mary Beth TerryHerbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.ORCID 0000-0002-4106-5033
Dominique FetzerDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-6374-0151
Jill Bennett GaieskiDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
Jessica BulafkaHerbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.ORCID 0000-0002-2865-073X
Aileen EspinalHerbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.
Kelsey KarpinkDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
Sarah WalserDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-7423-8973
Davone SingletonDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
Monica PaleseThe University of Chicago, Chicago, IL.ORCID 0000-0002-2624-0868
Ilona SiljanderThe University of Chicago, Chicago, IL.
Amanda BrandtDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-1617-0771
Dana ClarkDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
Carrie KovalDepartment of Pediatrics, Columbia University Irving Medical Center, New York City, NY.
Julia WynnDepartment of Pediatrics, Columbia University, New York City, NY.
Jessica M LongDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-0382-7890
Danielle McKennaDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-8317-1520
Jacquelyn PowersDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-9444-7169
Sarah NielsenThe University of Chicago, Chicago, IL.ORCID 0000-0002-5916-6393
Susan M DomchekDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-5914-7272
Katherine L NathansonDivision of Translational Medicine and Human Genetics, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-6740-0901
Angela R BradburyDivision of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-9607-6402
University of Pennsylvania · USColumbia University Irving Medical Center · USUniversity of Chicago · USFox Chase Cancer Center · USColumbia University · USUniversity of Utah · US

Funding

Returning genetic research panel results for breast cancer susceptibilityR01CA190871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2014 to 2025
$6.7M
Identifying and validating novel susceptibility genes for breast cancerR01CA176785 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH, NATHANSON, KATHERINE L. · 2014 to 2018
$3.4M
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and GenomicsT32HG009496 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Steven Joffe · 2017 to 2026
$3.4M
Evaluating the Risks and Benefits of the Next Generation of Direct-to-Consumer Genetic TestsK01HG010903 · NHGRI · UNIVERSITY OF UTAH · PI KILBRIDE, MADISON K · 2020 to 2023
$695k
NCI NIH HHS R01 CA176785NCI NIH HHS R01 CA190871NHGRI NIH HHS K01 HG010903NHGRI NIH HHS T32 HG009496
6 · The paper itself

Abstract

purposeWe developed a web-based education intervention as an alternative to predisclosure education with a genetic counselor (GC) to reduce participant burden and provider costs with return of genetic research results.

methodsWomen at three sites who participated in 11 gene discovery research studies were contacted to consider receiving cancer genetic research results. Participants could complete predisclosure education through web education or with a GC. Outcomes included uptake of research results, factors associated with uptake, and patient-reported outcomes.

resultsOf 819 participants, 178 actively (21.7%) and 167 passively (20.4%) declined return of results; 474 (57.9%) were enrolled. Most (60.3%) received results although this was lower than the 70% uptake we hypothesized. Passive and active decliners were more likely to be Black, to have less education, and to have not received phone follow-up after the invitation letter. Most participants selected web education (88.5%) as an alternative to speaking with a GC, but some did not complete or receive results. Knowledge increased significantly from baseline to other time points with no significant differences between those who received web versus GC education. There were no significant increases in distress between web and GC education.

conclusionInterest in web-based predisclosure education for return of genetic research results was high although it did not increase uptake of results. We found no negative patient-reported outcomes with web education, suggesting that it is a viable alternative delivery model for reducing burdens and costs of returning genetic research results. Attention to attrition and lower uptake of results among Black participants and those with less formal education are important areas for future research.

Indexed as

Patient Reported Outcome MeasuresTelephoneEducational StatusFemaleGenetic ResearchHumansInternet

Identifiers

PMID37611220
PMCPMC10617912
OpenAlexW4386100445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.